X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (44175) 44175
Book Chapter (115) 115
Book / eBook (103) 103
Newsletter (84) 84
Magazine Article (51) 51
Dissertation (12) 12
Newspaper Article (8) 8
Conference Proceeding (6) 6
Reference (6) 6
Book Review (2) 2
Publication (2) 2
Streaming Video (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (27599) 27599
animals (21681) 21681
immunology (17300) 17300
female (15689) 15689
male (13311) 13311
mice (13134) 13134
adult (6949) 6949
middle aged (6289) 6289
research article (6143) 6143
research (6104) 6104
immunotherapy (5544) 5544
immunologic diseases. allergy (5008) 5008
immunologic factors - therapeutic use (4911) 4911
proteins (4803) 4803
health aspects (4776) 4776
lymphocytes (4686) 4686
cytokines (4612) 4612
antigens (4593) 4593
treatment outcome (4453) 4453
immune system (4448) 4448
medicine (4392) 4392
dendritic cells (4276) 4276
vaccines (4275) 4275
immune response (4228) 4228
inflammation (4156) 4156
mice, inbred c57bl (4144) 4144
cancer (4050) 4050
t cells (3968) 3968
aged (3966) 3966
mice, inbred balb c (3956) 3956
analysis (3884) 3884
time factors (3798) 3798
adjuvants, immunologic - administration & dosage (3797) 3797
oncology (3756) 3756
care and treatment (3665) 3665
infections (3571) 3571
immunologic factors - administration & dosage (3560) 3560
biology (3553) 3553
multidisciplinary sciences (3530) 3530
microbiology (3509) 3509
lymphocytes t (3467) 3467
infectious diseases (3464) 3464
expression (3438) 3438
medicine, research & experimental (3316) 3316
science (3264) 3264
cell biology (3222) 3222
immunity (3171) 3171
vaccination (3129) 3129
disease models, animal (3013) 3013
immunization (3010) 3010
antibodies (3002) 3002
biology and life sciences (2959) 2959
virology (2814) 2814
medicine and health sciences (2796) 2796
gene expression (2770) 2770
adolescent (2752) 2752
physiological aspects (2681) 2681
t-lymphocytes - immunology (2678) 2678
activation (2654) 2654
allergy (2611) 2611
rodents (2605) 2605
therapy (2592) 2592
risk factors (2551) 2551
infection (2528) 2528
pharmacology & pharmacy (2461) 2461
rats (2452) 2452
disease (2451) 2451
medical research (2448) 2448
studies (2434) 2434
child (2394) 2394
t-cells (2346) 2346
in-vivo (2341) 2341
cells, cultured (2308) 2308
review (2231) 2231
immunoglobulins (2229) 2229
research and analysis methods (2224) 2224
parasitology (2222) 2222
allergy and immunology (2193) 2193
adjuvants, immunologic - pharmacology (2175) 2175
immunological tolerance (2145) 2145
hematology (2129) 2129
apoptosis (2116) 2116
flow cytometry (2115) 2115
immunologic factors - pharmacology (2103) 2103
drug therapy (2091) 2091
cells (2053) 2053
patients (2050) 2050
viruses (2038) 2038
biochemistry (2023) 2023
tumors (2008) 2008
transplantation (1917) 1917
children (1911) 1911
young adult (1906) 1906
immunologic techniques (1893) 1893
clinical trials (1889) 1889
adjuvants, immunologic - therapeutic use (1875) 1875
genetic aspects (1847) 1847
dose-response relationship, immunologic (1837) 1837
physiology (1816) 1816
animal models (1784) 1784
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (52) 52
Collection Dvlpm't (Acquisitions) - Vendor file (8) 8
Collection Dvlpm't (Acquisitions) - Closed Orders (7) 7
St. Michael's College (John M. Kelly) - 2nd Floor (6) 6
Online Resources - Online (5) 5
New College (Ivey) - Stacks (4) 4
UofT at Scarborough - Stacks (4) 4
Robarts - Stacks (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
UTL at Downsview - May be requested (3) 3
UofT at Mississauga - Stacks (3) 3
OISE - Stacks (2) 2
St. Michael's Hospital - Stacks (2) 2
Trinity College (John W Graham) - Stacks (2) 2
Criminology - Stacks (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Law (Bora Laskin) - Stacks (1) 1
St. Augustine's Seminary - Stacks (1) 1
St. Michael's College (John M. Kelly) - Circulation Desk (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
Trillium Health Centre - Reserve desk (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (43543) 43543
Russian (574) 574
Japanese (283) 283
German (231) 231
French (146) 146
Spanish (84) 84
Chinese (68) 68
Portuguese (46) 46
Italian (44) 44
Polish (34) 34
Hungarian (20) 20
Norwegian (16) 16
Ukrainian (16) 16
Bulgarian (13) 13
Danish (12) 12
Dutch (12) 12
Czech (7) 7
Romanian (6) 6
Swedish (5) 5
Turkish (5) 5
Arabic (4) 4
Hebrew (3) 3
Serbian (3) 3
Finnish (2) 2
Korean (2) 2
Lithuanian (2) 2
Slovak (2) 2
Croatian (1) 1
Zulu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2010, Volume 362, Issue 2, pp. 118 - 128
Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 2015, Volume 112, Issue 2, pp. E156 - E165
Current treatments to control pathological or unwanted immune responses often use broadly immunosuppressive drugs. New approaches to induce antigen-specific... 
Nanoparticles | Rapamycin | Anti-drug antibodies | Immune tolerance | Immunotherapy | THERAPEUTICS | anti-drug antibodies | IMMUNITY | TOLEROGENIC DENDRITIC CELLS | RISK-FACTORS | MULTIDISCIPLINARY SCIENCES | FACTOR-VIII | MECHANISMS | RESPONSES | immune tolerance | IMMUNOGENICITY | nanoparticles | UNRESPONSIVENESS | immunotherapy | rapamycin | Factor VIII - immunology | Oligodeoxyribonucleotides - administration & dosage | Nanoparticles - chemistry | Ovalbumin - immunology | Immunosuppression - methods | Nanocapsules - administration & dosage | Humans | Encephalomyelitis, Autoimmune, Experimental - immunology | Hypersensitivity, Delayed - immunology | Nanocapsules - chemistry | Peptides - administration & dosage | Antigens - administration & dosage | CD4-Positive T-Lymphocytes - immunology | Immunity, Humoral | Peptide Fragments - immunology | Proteins - administration & dosage | Female | Immunosuppressive Agents - administration & dosage | Disease Models, Animal | Lactic Acid - chemistry | Peptides - chemistry | Hemophilia A - immunology | Peptide Fragments - administration & dosage | Peptides - immunology | Immune Tolerance | Hemophilia A - therapy | Hypersensitivity, Delayed - therapy | Antigens - chemistry | Proteins - immunology | Encephalomyelitis, Autoimmune, Experimental - therapy | Sirolimus - administration & dosage | Animals | Ovalbumin - administration & dosage | Recombinant Proteins - immunology | Polyglycolic Acid - chemistry | Encephalomyelitis, Autoimmune, Experimental - prevention & control | Mice | Mice, Inbred BALB C | Nanoparticles - administration & dosage | Hemocyanins - administration & dosage | Proteins - chemistry | Antigens | Usage | Research | Health aspects | Immunological tolerance | Immunological research | Biological Sciences | PNAS Plus
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 378, Issue 4, pp. 331 - 344
In a large randomized trial that compares regimens in which brentuximab vedotin replaced bleomycin, the group receiving the brentuximab had a 4.9... 
TRIAL | ABVD | MEDICINE, GENERAL & INTERNAL | POSITRON-EMISSION-TOMOGRAPHY | RESPONSE CRITERIA | DISEASE | PROGNOSTIC SCORE | OPEN-LABEL | TOXICITY | INTERGROUP | COOPERATIVE-ONCOLOGY-GROUP | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - administration & dosage | Immunoconjugates - administration & dosage | Young Adult | Aged, 80 and over | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Brentuximab Vedotin | Neutropenia - chemically induced | Doxorubicin - administration & dosage | Immunoconjugates - adverse effects | Dacarbazine - administration & dosage | Immunologic Factors - administration & dosage | Survival Rate | Bleomycin - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Aged | Immunologic Factors - adverse effects | Neoplasm Staging | Vinblastine | Hematology | Toxicity | Prophylaxis | Clinical trials | Oncology | Peripheral neuropathy | Cancer therapies | Doxorubicin | Survival | Lymphoma | Medicine | Dacarbazine | Chemotherapy | Bleomycin | CD30 antigen | Granulocyte colony-stimulating factor | Death | Colony-stimulating factor | Lymphomas | Leukocytes (granulocytic) | Drug dosages | Hodgkin's disease | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
Clinical gastroenterology and hepatology, ISSN 1542-3565, 2013, Volume 11, Issue 3, pp. 286 - 292
Journal Article
Clinical gastroenterology and hepatology, ISSN 1542-3565, 2016, Volume 14, Issue 8, pp. 1120 - 1129.e6
Journal Article
Neoplasia, ISSN 1476-5586, 2011, Volume 13, Issue 12, pp. 1143 - 1151
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2019, Volume 381, Issue 10, pp. 923 - 932
...–macrophage colony-stimulating factor resulted in a significantly better alveolar–arterial oxygen gradient at 25 weeks than the use of placebo... 
ANTIBODIES | AUTOANTIBODIES | MEDICINE, GENERAL & INTERNAL | THERAPY | COLONY-STIMULATING FACTOR | EFFICACY | MICE | Recombinant Proteins - therapeutic use | Smoking - adverse effects | Autoimmune Diseases - diagnostic imaging | Autoantibodies - blood | Humans | Middle Aged | Pulmonary Alveolar Proteinosis - diagnostic imaging | Male | Tomography, X-Ray Computed | Lung - diagnostic imaging | Recombinant Proteins - adverse effects | Granulocyte-Macrophage Colony-Stimulating Factor - therapeutic use | Adult | Female | Autoimmune Diseases - drug therapy | Pulmonary Alveolar Proteinosis - drug therapy | Granulocyte-Macrophage Colony-Stimulating Factor - administration & dosage | Lung - pathology | Double-Blind Method | Drug Administration Schedule | Immunologic Factors - administration & dosage | Administration, Inhalation | Oxygen - blood | Recombinant Proteins - administration & dosage | Granulocyte-Macrophage Colony-Stimulating Factor - adverse effects | Pulmonary Diffusing Capacity | Granulocyte-Macrophage Colony-Stimulating Factor - immunology | Pulmonary Alveolar Proteinosis - immunology | Aged | Immunologic Factors - adverse effects | Walk Test | Immunologic Factors - therapeutic use | Treatment outcome | Usage | Safety and security measures | Pulmonary alveolar proteinosis | Analysis | Drug therapy | Granulocyte-macrophage colony stimulating factor | Medical research | Autoantibodies | Laboratories | Granulocyte-macrophage colony-stimulating factor | Research & development--R&D | Clinical trials | Surfactants | Patients | Proteins | Dyspnea | Computed tomography | Colony-stimulating factor | Blood pressure | Chronic obstructive pulmonary disease | Oxygen tension | Alveoli
Journal Article
Clinical gastroenterology and hepatology, ISSN 1542-3565, 2013, Volume 11, Issue 5, pp. 558 - 564.e3
Journal Article